Serological evidence of infections and Type 2 diabetes: The Multiethnic Study of Atherosclerosis: Original Article: Epidemiology

Diabetic Medicine

Volumn 26, Issue 2, 2009, Pages 149-152

  Lutsey, P L ^a,b   Pankow, J S ^b   Bertoni, A G ^c   Szklo, M ^d   Folsom, A R ^b  

^a University of Minnesota ^*  (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Diabetes; Infection; Pathogen; Seropositivity

Indexed keywords

C REACTIVE PROTEIN; FIBRINOGEN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CYTOMEGALOVIRUS; DISEASE MARKER; FEMALE; HELICOBACTER PYLORI; HEPATITIS A VIRUS; HERPES SIMPLEX VIRUS; HUMAN; INFECTION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PREVALENCE; SEROLOGY;

EID: 60049100702     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02632.x     Document Type: Article

References (25)

1. Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes 2004 53 : 693 700.
2. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001 286 : 327 334.
3. Spranger J, Kroke A, Mohlig M, Hoffmann K, Bergmann MM, Ristow M et al. Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into cancer and nutrition (EPIC)-potsdam study. Diabetes 2003 52 : 812 817.
4. Thorand B, Lowel H, Schneider A, Kolb H, Meisinger C, Frohlich M et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: results from the MONICA augsburg cohort study, 1984-1998. Arch Intern Med 2003 163 : 93 99.
5. Thorand B, Kolb H, Baumert J, Koenig W, Chambless L, Meisinger C et al. Elevated levels of interleukin-18 predict the development of type 2 diabetes: results from the MONICA/KORA augsburg study, 1984-2002. Diabetes 2005 54 : 2932 2938.
6. Doi Y, Kiyohara Y, Kubo M, Ninomiya T, Wakugawa Y, Yonemoto K et al. Elevated C-reactive protein is a predictor of the development of diabetes in a general Japanese population: the hisayama study. Diabetes Care 2005 28 : 2497 2500.
7. Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care 2003 26 : 2754 2757.
8. Rutter MK, Meigs JB, Sullivan LM, D'Agostino RB, Sr., Wilson PWF. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the Framingham offspring study. Circulation 2004 110 : 380 385.
9. Festa A, D'Agostino R, Jr., Tracy RP, Haffner SM. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes 2002 51 : 1131 1137.
10. Dandona P, Aljada A, Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 2004 25 : 4.
11. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR et al. Multi-ethnic study of atherosclerosis: objectives and design. Am J Epidemiol 2002 156 : 871 881.
12. Roberts BW, Cech I. Association of type 2 diabetes mellitus and seroprevalence for cytomegalovirus. South Med J 2005 98 : 686 692.
13. Sun Y, Pei W, Wu Y, Yang Y. An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care 2005 28 : 435 436.
14. Quadri R, Rossi C, Catalfamo E, Masoero G, Lombardo L, Della Monica P et al. Helicobacter pylori infection in type 2 diabetic patients. Nutr Metab Cardiovasc Dis 2000 10 : 263 266.
15. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005 28 : 214 217.
16. Quatrini M, Boarino V, Ghidoni A, Baldassarri AR, Bianchi PA, Bardella MT. Helicobacter pylori prevalence in patients with diabetes and its relationship to dyspeptic symptoms. J Clin Gastroenterol 2001 32 : 215 217.
17. Longo-Mbenza B, Nkondi Nsenga J, Vangu Ngoma D. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics. Int J Cardiol 2007 121 : 229 238.
18. Xia HH-X, Talley NJ, Kam EPY, Young LJ, Hammer J, Horowitz M. Helicobacter pylori infection is not associated with diabetes mellitus, nor with upper gastrointestinal symptoms in diabetes mellitus. Am J Gastroenterol 2001 96 : 1039 1046.
19. Li-Ng M, Tropp S, Danoff A, Bini EJ. Association between chronic hepatitis B virus infection and diabetes among Asian Americans and Pacific Islanders. Digest Liver Dis 2007 39 : 549.
20. Antonelli A, Ferri C, Fallahi P, Pampana A, Ferrari SM, Goglia F et al. Hepatitis C virus infection: evidence for an association with type 2 diabetes. Diabetes Care 2005 28 : 2548 2550.
21. Wang C-S, Wang S-T, Yao W-J, Chang T-T, Chou P. Community-based study of hepatitis C virus infection and type 2 diabetes: an association affected by age and hepatitis severity status. Am J Epidemiol 2003 158 : 1154 1160.
22. Mehta SH, Brancati FL, Strathdee SA, Pankow JS, Netski D, Coresh J et al. Hepatitis C virus infection and incident type 2 diabetes. Hepatology 2003 38 : 50 56.
23. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000 133 : 592 599.
24. Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 2006 94 : 10 21.
25. Butler SO, Btaiche IF, Alaniz C. Relationship between hyperglycemia and infection in critically ill patients. Pharmacotherapy 2005 25 : 963 976.